DCM Shriram reported a 9% year-on-year rise in consolidated net revenue to ₹3,564 crore for Q1 FY27. While operational profit grew, the reported net profit included a significant one-time tax adjustment.
DCM Shriram Reports Strong Operational Growth in Q1 FY27
DCM Shriram's net revenue increased by 9% to ₹3,564 crore in the first quarter of FY27, while PBDIT grew 12% to ₹364 crore. The reported profit after tax (PAT) of ₹693 crore includes a ₹474 crore tax adjustment and ₹79 crore from asset sales. Excluding these non-recurring items, the adjusted PAT rose by 28% to ₹147 crore.
Reader Takeaway: Operational strength in Chemicals and Fenesta, but weather impacts agriculture business. Focus on capex and demerger.
What just happened
DCM Shriram announced its financial results for the first quarter of the fiscal year 2027. The company reported an increase in net revenue and operational profits. However, the reported net profit was significantly influenced by a one-time tax adjustment and gains from asset sales.
Why this matters
The results indicate underlying business momentum, particularly in key segments like Chemicals. Investors will watch how the company manages its planned capital expenditure and the progress on its proposed demerger. Understanding the impact of one-time items on the profit is crucial for assessing true operational performance.
The backstory
DCM Shriram is a diversified business group with interests spanning Agri-Rural, Chloro-Vinyl, and Value-added businesses. The company has been focusing on expanding its capacities and improving its product mix. The proposed demerger aims to unlock value by separating its various business verticals.
What changes now
The company is proceeding with its planned capital expenditure of ₹1,000 crore for FY27 and is actively working on organizational requirements for the demerger. Investors should track the utilization of MAT credit and the effective cash tax rate going forward.
Risks to watch
Import pressures in the Vinyl segment and delays in sowing acreage due to delayed monsoons, impacting the Bioseed segment, are key risks. The company continues to monitor these factors.
Peer comparison
While specific peer financials are not provided in the filing, DCM Shriram's Chemicals segment performance is significant in a sector often characterized by cyclicality and input cost pressures. Its Fenesta Building Systems business operates in a growing construction and real estate market.
Context metrics (time-bound)
- Net Revenue: ₹3,564 crore (Q1 FY27) vs ₹3,262 crore (Q1 FY26) - up 9%.
- PBDIT: ₹364 crore (Q1 FY27) vs ₹326 crore (Q1 FY26) - up 12%.
- Adjusted PAT: ₹147 crore (Q1 FY27).
- Fenesta Order Book: ₹1,000 crore.
- Planned Capex for FY27: ₹1,000 crore.
- Net Debt: ₹1,649 crore (June 30, 2026) vs ₹1,481 crore (year earlier).
What to track next
Investors should monitor the progress of the demerger, the successful execution of the ₹1,000 crore capex plan, and the recovery of the Bioseed segment, especially its response to monsoon patterns. Performance of the Vinyl segment amidst import competition will also be key.